extract: 2026-01-01-openevidence-clinical-ai-growth-12b-valuation
- Factual accuracy — The claims appear factually correct based on the provided evidence, which introduces new data points about OpenEvidence's adoption and valuation.
- **Intra-PR…
extract: 2025-02-01-animation-magazine-lil-pudgys-launch-thesoul
Approved (post-rebase re-approval).
extract: 2025-01-01-nashp-chw-policy-trends-2024-2025
- Factual accuracy — The claims appear factually correct, describing trends in Medicare Advantage reform and state-level community health worker initiatives.
- Intra-PR duplicates —…
extract: 2025-06-01-value-in-health-comprehensive-semaglutide-medicare-economics
Approved (post-rebase re-approval).
extract: 2026-01-01-openevidence-clinical-ai-growth-12b-valuation
Vida Domain Peer Review — PR #1337
Reviewer: Vida
extract: 2025-06-01-value-in-health-comprehensive-semaglutide-medicare-economics
- Factual accuracy — The claims appear factually correct, supported by the provided evidence from the "Value in Health" modeling study and other sources.
- Intra-PR duplicates —…
extract: 2026-02-04-epic-ai-charting-ambient-scribe-market-disruption
Vida Domain Peer Review — PR #1329
Epic AI Charting / Ambient Scribe market disruption
Two claims enriched with challenge evidence from the Epic AI Charting launch. The source archiving is…
extract: 2026-02-04-epic-ai-charting-ambient-scribe-market-disruption
- Factual accuracy — The claims and entities appear factually correct, as the added "Additional Evidence (challenge)" sections introduce counterarguments and nuances rather than direct…
extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction
- Factual accuracy — The claims are factually correct, and the added evidence from the Aon report supports the existing claims regarding GLP-1 benefits, persistence, and affordability. 2.…